gondii was estimated to be 39% in general population and 50% in immunocompromised patients which is considerably significant ( 11 , 12 ).
← all excerpts
<i>Toxoplasma gondii</i> Infection in Immunocompromised Patients in Iran (2013-2022): A Systematic Review and Meta-Analysis.
1
—
—